Myriad Genetics (MYGN) Current Taxes (2014 - 2020)

Myriad Genetics has disclosed Current Taxes across 7 years of filings, most recently posting $6.1 million for Q2 2020.

• In Q2 2020, Current Taxes rose 103.33% year-over-year to $6.1 million; the TTM figure through Jun 2020 stood at $6.1 million (up 103.33% YoY), while the FY2020 annual figure was $6.1 million, up 103.33% from the prior year.
• Current Taxes climbed to $6.1 million in Q2 2020, from $3.5 million in the prior quarter.
• Over the last five years, Current Taxes for MYGN reached as high as $9.8 million in Q3 2018 and fell as low as $2.3 million in Q1 2016.
• The 5-year median for Current Taxes is $3.6 million (2019), against an average of $4.6 million.
• Annual changes were most pronounced in 2017 — Current Taxes surged 168.75% — and 2018, when it slumped 39.44%.
• A 5-year view of Current Taxes shows it stood at $3.0 million in 2016, then gained by 6.67% to $3.2 million in 2017, then soared by 53.12% to $4.9 million in 2018, then declined by 18.37% to $4.0 million in 2019, then surged by 52.5% to $6.1 million in 2020.
• According to Business Quant data, Current Taxes over the past three periods registered $6.1 million, $3.5 million, and $4.0 million for Q2 2020, Q1 2020, and Q4 2019 respectively.